Kronos Bio Inc’s recently made public that its SR VP, CORP OPERATIONS & LEGAL Frisbee Allison unloaded Company’s shares for reported $12757.0 on Feb 21 ’24. In the deal valued at $1.05 per share,12,105 shares were sold. As a result of this transaction, Frisbee Allison now holds 204,510 shares worth roughly $0.22 million.
Then, Lin Charles Y sold 12,036 shares, generating $12,685 in total proceeds. Upon selling the shares at $1.05, the SR VP, RESEARCH & DEVELOPMENT now owns 234,603 shares.
Before that, Olek Elizabeth A sold 7,368 shares. Kronos Bio Inc shares valued at $7,765 were divested by the SR VP, CLINICAL SCIENCE at a price of $1.05 per share. As a result of the transaction, Olek Elizabeth A now holds 193,275 shares, worth roughly $0.21 million.
Berenberg initiated its Kronos Bio Inc [KRON] rating to a Buy in a research note published on September 14, 2022; the price target was $12. H.C. Wainwright began covering KRON with “Buy” recommendation on June 24, 2021. Piper Sandler started covering the stock on November 03, 2020. It rated KRON as “an Overweight”.
Price Performance Review of KRON
On Tuesday, Kronos Bio Inc [NASDAQ:KRON] saw its stock fall -4.39% to $1.09. Over the last five days, the stock has lost -3.54%. Kronos Bio Inc shares have fallen nearly -12.80% since the year began. Nevertheless, the stocks have fallen -16.15% over the past one year. While a 52-week high of $2.29 was reached on 03/11/24, a 52-week low of $0.73 was recorded on 03/01/24. SMA at 50 days reached $1.1504, while 200 days put it at $1.2852. A total of 0.26 million shares were traded, compared to the trading of 67200.0 shares in the previous session.
Levels Of Support And Resistance For KRON Stock
The 24-hour chart illustrates a support level at 1.0467, which if violated will result in even more drops to 1.0033. On the upside, there is a resistance level at 1.1467. A further resistance level may holdings at 1.2033. The Relative Strength Index (RSI) on the 14-day chart is 41.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0814, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.62%. Stochastics %K at 9.30% indicates the stock is a buying.
The most recent change occurred on November 03, 2020 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $36 price target.
